investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Microenvironment mediated drug resistance in melanoma
Keiran Smalley
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Keiran Smalley
Moffitt Cancer Center
Tampa, United States
University of South Florida
Tampa, United States
Related projects
Giovanni Luigi Parmigiani
Bioinformatics Tools for Genomic Analysis of Tumor and Stromal Pathways in Cancer
Melanoma of skin
Laura D Attardi
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
Melanoma of skin
Paula Louise Fischhaber
Recruitment of End-Processing Factors in DSB Repair
Melanoma of skin
Yubin Zhou
Molecular control of calcium influx at the ER-plasma membrane junctions
Melanoma of skin
Anne E Anderson
Signaling pathway dysregulation in epilepsy
Melanoma of skin
Anna Bianchi-Smiraglia
GTP Metabolism Controls Tumor Invasion
Melanoma of skin
Jennifer Q Zhang
Tyrosine kinase inhibition and immunomodulation for cancer
Melanoma of skin
Boussiotis Vassiliki A
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
Melanoma of skin
Dewi Harjanto
Does the RNA editor Apobec-1 shift microRNA targeting to a tumorigenic effect?
Melanoma of skin